[Iloprost for the treatment of digital ischaemia in pediatric septic shock].
García Soler
Patricia
P
Milano Manso
Guillermo
G
Camacho Alonso
José Miguel
JM
Manuel González
José
J
D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003428:Cross Infection / Q000150:complications; D003646:Debridement; D017809:Fatal Outcome; D005385:Fingers / Q000098:blood supply*; D005734:Gangrene; D006801:Humans; D016285:Iloprost / Q000627:therapeutic use*; D007223:Infant; D007511:Ischemia / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D008297:Male; D008585:Meningitis, Meningococcal / Q000150:complications; D009102:Multiple Organ Failure / Q000209:etiology; D005996:Nitroglycerin / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012772:Shock, Septic / Q000150:complications*; D013203:Staphylococcal Infections / Q000150:complications; D014034:Toes / Q000098:blood supply*; D014402:Tuberous Sclerosis / Q000150:complications; D014665:Vasodilator Agents / Q000627:therapeutic use*
D043925:Angiogenesis Inducing Agents; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D005996:Nitroglycerin; D016285:Iloprost